Based on literature reports and our findings, we speculate that the HLA-DPB2/HLA-DPB1 axis may convert immunologically “cold” tumors to “hot” tumors and thus exert an anticancer role in BC by recruiting T lymphocytes and NK cells into the tumor microenvironment. This evidence concerns the gene HLA-DPB1 and breast cancer.